Fourth-generation chimeric antigen receptor T-cell therapy is tolerable and efficacious in treatment-resistant rheumatoid arthritis

Li Y, Li S, Zhao X, Sheng J, Xue L, Schett G, Shi C, Hu B, Wang X, Chen Z (2025)

Publication Type: Journal article

Publication year: 2025

Journal

Cell Research Nature Publishing Group: Open Access Hybrid Model Option B

Article Number: eabq4419

DOI: 10.1038/s41422-024-01068-2

Authors with CRIS profile

Georg Schett Lehrstuhl für Innere Medizin III

Involved external institutions

University of Science and Technology of China (USTC) CN China (CN) Wannan Medical College / 皖南医学院 CN China (CN)

How to cite

APA:

Li, Y., Li, S., Zhao, X., Sheng, J., Xue, L., Schett, G.,... Chen, Z. (2025). Fourth-generation chimeric antigen receptor T-cell therapy is tolerable and efficacious in treatment-resistant rheumatoid arthritis. Cell Research. https://doi.org/10.1038/s41422-024-01068-2

MLA:

Li, Yujing, et al. "Fourth-generation chimeric antigen receptor T-cell therapy is tolerable and efficacious in treatment-resistant rheumatoid arthritis." Cell Research (2025).

BibTeX: Download